bluebird bio, Inc. (Nasdaq:BLUE) a clinical-stage company committed to
developing potentially transformative gene therapies for severe genetic
and rare diseases, today announced that the U.S. Food and Drug
Administration (FDA) has granted Breakthrough Therapy designation to
LentiGlobin ® BB305 Drug Product for the treatment of
transfusion-dependent patients with beta-thalassemia major.
Provides high speed in-flight broadband connectivity to airlines worldwide
Operable at all latitudes, including equatorial, based on breakthrough steerable pointing system
Optimized for use with upcoming Ku-band HTS satellites and fully compatible with current Ku satellite systems
Compatible with Global Eagle's current certifications and future line fit installations
First installation of the new global antenna expected in mid-2016
LOS ANGELES and HOLZGERLINGEN, Germany, Feb.
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage
pharmaceutical company focused on the discovery, development and
commercialization of first-in-class therapies for the treatment of
patients with glaucoma and other diseases of the eye, announced today
potentially breakthrough findings from new preclinical research.
Freescale Semiconductor (NYSE: FSL), the global leader in radio
frequency (RF) power transistors , today introduced the industry’s
highest thermal and wideband performance GaN device with a 125 watts
continuous wave (CW) GaN-on-SiC transistor.
Today GE Transportation ( www.getransportation.com )
announced the first delivery of its latest marine diesel engines to GE
Marine distributor Cummins Mid-South ( www.cumminsmidsouth.com ).
The new engines meet EPA Tier 4 and IMO Tier III Emissions standards
(ABS Certification and Green Passport) -- reducing NOx emissions by 70
percent when compared to EPA Tier 2 or IMO Tier II.
BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in mobile
communications, and NantHealth, a cloud-based information technology
provider combining science and big data to transform healthcare, today
announced the first secure clinical genome browser that gives doctors
unprecedented access to patients’ genetic data on the BlackBerry®
Passport smartphone – the NantOmics Cancer Genome Browser™.
The NantOmics Cancer Genome Browser platform on the BlackBerry Passport
enables deep, interactive reporting on genomics data for physicians and
other treatment providers in clinical settings – for example, giving
oncologists a powerful view into the individual genetic alternations
that make each patient’s disease unique and highlighting relevant
Positive Results of Largest Genomic Study in DCIS Reconfirm Oncotype DX is a Strong, Independent Predictor of Local Recurrence Oral Presentation, Featured in the 2014 San Antonio Breast Cancer Symposium Press Program, to Occur on December 12 at 10:15 a.m. Central Time
SAN ANTONIO , Dec.
- BeyondStudio revolutionizes the JN516x software development experience, matching or exceeding competing products in ease of use, productivity and code quality
EINDHOVEN, The Netherlands and LJUBLJANA, Slovenia, Dec.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.